Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Rituximab with chemotherapy improves survival of non-germinal center type untreated diffuse large B-cell lymphoma.

× No keyword cloud information.

13 in total

Review 1. Stem cell transplantation in childhood non-Hodgkin's lymphomas.

Authors: Fatma V Okur; Robert Krance
Journal: Curr Hematol Malig Rep Date: 2010-10 Impact factor: 3.952

2. Pediatric diffuse large B-cell lymphoma demonstrates a high proliferation index, frequent c-Myc protein expression, and a high incidence of germinal center subtype: Report of the French-American-British (FAB) international study group.

Authors: Rodney R Miles; Martine Raphael; Keith McCarthy; Andrew Wotherspoon; Mark A Lones; Marie J Terrier-Lacombe; Catherine Patte; Mary Gerrard; Anne Auperin; Richard Sposto; Virginia Davenport; Mitchell S Cairo; Sherrie L Perkins
Journal: Pediatr Blood Cancer Date: 2008-09 Impact factor: 3.167

3. Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in Japan: a retrospective analysis of 1,057 cases from Kyushu Lymphoma Study Group.

Authors: Ritsuko Seki; Koichi Ohshima; Koji Nagafuji; Tomoaki Fujisaki; Naokuni Uike; Fumio Kawano; Hisashi Gondo; Shigeyoshi Makino; Tetsuya Eto; Yukiyoshi Moriuchi; Fumihiro Taguchi; Tomohiko Kamimura; Hiroyuki Tsuda; Ryosuke Ogawa; Kazuya Shimoda; Kiyoshi Yamashita; Keiko Suzuki; Hitoshi Suzushima; Kunihiro Tsukazaki; Masakazu Higuchi; Atae Utsunomiya; Masahiro Iwahashi; Yutaka Imamura; Kazuo Tamura; Junji Suzumiya; Minoru Yoshida; Yasunobu Abe; Tadashi Matsumoto; Takashi Okamura
Journal: Int J Hematol Date: 2010-03 Impact factor: 2.490

4. T-cell immunotherapy with a chimeric receptor against CD38 is effective in eradicating chemotherapy-resistant B-cell lymphoma cells overexpressing survivin induced by BMI-1.

Authors: J Bhattacharyya; K Mihara; A Kitanaka; K Yanagihara; T Kubo; Y Takei; A Kimura; Y Takihara
Journal: Blood Cancer J Date: 2012-06-22 Impact factor: 11.037

5. The expression of CD30 based on immunohistochemistry predicts inferior outcome in patients with diffuse large B-cell lymphoma.

Authors: Xiaoxiao Hao; Xiaolei Wei; Fen Huang; Yongqiang Wei; Hong Zeng; Linwei Xu; Qinjun Zhou; Ru Feng
Journal: PLoS One Date: 2015-05-14 Impact factor: 3.240

6. Influence of NK cell count on the survival of patients with diffuse large B-cell lymphoma treated with R-CHOP.

Authors: Joong-Keun Kim; Joo-Seop Chung; Ho-Jin Shin; Moo-Kon Song; Ji-Won Yi; Dong-Hun Shin; Dae-Sung Lee; Sung-Min Baek
Journal: Blood Res Date: 2014-09-25

7. Clinical significance of nuclear factor κB and chemokine receptor CXCR4 expression in patients with diffuse large B-cell lymphoma who received rituximab-based therapy.

Authors: Ho Cheol Shin; Jongwon Seo; Byung Woog Kang; Joon Ho Moon; Yee Soo Chae; Soo Jung Lee; Yoo Jin Lee; Seoae Han; Sang Kyung Seo; Jong Gwang Kim; Sang Kyun Sohn; Tae-In Park
Journal: Korean J Intern Med Date: 2014-10-31 Impact factor: 2.884

8. Klotho, an anti-aging gene, acts as a tumor suppressor and inhibitor of IGF-1R signaling in diffuse large B cell lymphoma.

Authors: Xiangxiang Zhou; Xiaosheng Fang; Yujie Jiang; Lingyun Geng; Xinyu Li; Ying Li; Kang Lu; Peipei Li; Xiao Lv; Xin Wang
Journal: J Hematol Oncol Date: 2017-02-02 Impact factor: 17.388

9. Role of radiation therapy in primary breast diffuse large B-cell lymphoma in the Rituximab era: a SEER database analysis.

Authors: Pan-Pan Liu; Ke-Feng Wang; Jie-Tian Jin; Xi-Wen Bi; Peng Sun; Yu Wang; Hang Yang; Zhi-Ming Li; Wen-Qi Jiang; Yi Xia
Journal: Cancer Med Date: 2018-04-06 Impact factor: 4.452

Review 10. Treatment of diffuse large B cell lymphoma.

Authors: Jae-Yong Kwak
Journal: Korean J Intern Med Date: 2012-11-27 Impact factor: 2.884